XtalPi Holdings Limited (HKG:2228)

Hong Kong · Delayed Price · Currency is HKD

6.61

+0.04 (0.61%)

Jun 18, 2026, 4:08 PM HKT

8.18% (1Y)

Market Cap	28.45B +53.8%
Revenue (ttm)	893.17M +201.2%
Net Income	137.71M
EPS	0.03
Shares Out	4.30B
PE Ratio	198.00
Forward PE	113.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	89,760,454
Open	6.66
Previous Close	6.57
Day's Range	6.50 - 6.77
52-Week Range	5.27 - 15.12
Beta	1.26
Analysts	Strong Buy
Price Target	11.63 (+75.95%)
Earnings Date	Aug 27, 2026

About XtalPi Holdings

XtalPi Holdings Limited operates as a research platform company in Mainland China, the United States, and internationally. The company offers XmartChem, an intelligent synthesis workstation which automates the chemical synthesis process; ChemPlus, desktop solid dispensing device; PatSight, an optical chemical structure extraction tool for patents; and XFEP, a software for rapid FEP calculations using cloud computing. It also provides XMolGen, a generative chemistry tool; and drug discovery solutions, such as hit discovery, hit or lead optimizat... [Read more]

Industry Health Information Services

Sector Healthcare

Founded 2015

Employees 1,254

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2228

Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 2228 stock is "Strong Buy." The 12-month stock price target is $11.63, which is an increase of 75.95% from the latest price.

Price Target

$11.63

(75.95% upside)

Analyst Consensus: Strong Buy

Stock Forecasts